Patient info Open main menu

Netvax - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - Netvax

.
  • D. STATEMENT OF THE MRLs .

    Pharmacologically active substance(s)

    Animal species

    Other provisions j

    Thiomersal

    All food producing species

    Annex II of Council Regulation (E EC) No. 2377/90

    EDTA

    All food producing species

    Annex II of Council^RegU|qtion (EEC) No. 2377/90

    Formaldehyde

    All food producing species

    Annex II of Council Regulation (EEC) No. 2377/90

    Mineral oil

    All food producing species

    Annex II of Council Regulation (EEC) No. 2377/90 W

    Benzyl alcohol

    All food producing species

    Annex II of Council Regulation (EEC) No. 2377/90

Triethanolamine (at doses up to 0.25 mg/kg bw) is considered not within the scope of Council Regulation (EEC) No. 2377/90.

Carton


PARTICULARS TO APPEAR ON THE OUTER PACKAGE

* International units per ml of rabbit serum determined by haemolysis i

3. PHARMACEUTICAL FORM

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES

Netvax

Emulsion for injection for chickens

4. PACKAGE SIZE

7. METH

5. TARGET SPECIES

1 × 500ml

6 × 500ml

ROUTE(S) OF ADMINISTRATION

THDRAWAL PERIOD

Intramuscular use.

Shake well before use. Read the package leaflet before use


Per dose of 0.5ml:

Clostridium perfringens Type A alpha toxoid: > 6.8 IU*

Light mineral oil: 0.31 ml

Thiomersal: 0.035–0.05 mg


Chickens


6. INDICATIONS


Vaccine against necro


awal period: Zero days


9. SPECIAL WARNING(S), IF NECESSARY


Accidental injection is dangerous – read package leaflet before use.


10. EXPIRY DATE


EXP month/year

Once opened, use within 8 hours


11. SPECIAL STORAGE CONDITIONS


Store and transport refrigerated (2°C- 8°C). Do not freeze Protect from light


12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF WASTE MATERIALS, IF ANY


Disposal: read package leaflet



13. THE WORDS “FOR ANIMAL TREATM

RESTRICTIONS REGARDING SUPPLY


For animal treatment only.

To be supplied only on veterinary prescription.


15. NAME AND ADDR


Intervet International B Wim de Korverstraat 5831AN Boxmeer The Netherlands


Keep out of the reach and sight

14. THE WORDS “KEEP OUT


16. MA

EU/2/09 EU/2/


PRODUCTS OR


ONLY” AND CONDITIONS OR

) USE, if applicable


REACH AND SIGHT OF CHILDREN


THE MARKETING AUTHORISATION HOLDER


G AUTHORISATION NUMBER(S)


Label


MINIMUM PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING UNITS

* International units per ml of rabbit serum determined by haemolysi

3. PHARMACEUTICAL FORM

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES

Netvax

Emulsion for injection for chickens

4. PACKAGE SIZE

7. METH

1 × 500ml

6 × 500ml

ROUTE(S) OF ADMINISTRATION

Intramuscular use.

Shake wore use. Read the package leaflet before use


Per dose of 0.5ml:

Clostridium perfringens Type A alpha toxoid: > 6.8 IU*

Light mineral oil: 0.31 ml

Thiomersal: 0.035–0.05 mg


5. TARGET SPECIES


Chickens


6. INDICATION(S)


Vaccine against necr


HDRAWAL PERIOD


awal period: Zero days


9. SPECIAL WARNING(S), IF NECESSARY

Accidental injection is dangerous – read package leaflet before use.


10. EXPIRY DATE


EXP month/year

Once opened, use within 8 hours

  • 11. SPECIAL STORAGE CONDITIONS

Store and transport refrigerated (2°C- 8°C). Do not freeze

Protect from light

PRODUCTS OR


  • 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL WASTE MATERIALS, IF ANY

  • 13. THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable

For animal treatment only.

To be supplied only on veterinary prescri

  • 14. THE WORDS “KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”

Keep out of the reach and sight of children.

  • 15. NAME AND ADD R ESS OF THE MARKETING AUTHORISATION HOLDER

Intervet International B.V

Wim de Korverstraat 35 5831AN Boxmeer The Netherlands

16.


NG AUTHORISATION NUMBER(S)


EU/2/


PACKAGE LEAFLET FOR

RODUCT

ANCE(S) AND OTHER INGREDIENT(S)

OF

CH


Netvax emulsion for injection for chickens


1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDE THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE F RELEASE, IF DIFFERENT


Marketing authorisation holder :


Intervet International B.V.

Wim de Körverstraat 35 5831AN Boxmeer The Netherlands


Manufacturer for the batch release:


S-P Veterinary Ltd Breakspear Road South Harefield

Uxbridge

Middlesex, UB9 6LS United Kingdom


2. NAME OF THE VETERINARY MEDIC


Netvax emulsion for injection for chickens


3. STATEMENT OF THE ACTIV


One dose (0.5ml) contains:

Active substance: Clostridium perfringens Ty

Adjuvant

Light Mineral Oil Excipients Thiomersal



ha toxoid Not less than 6.8 IU


0.31 ml


0.035–0.05 mg


International units per ml of rabbit serum determined by haemolysis inhibition assay


For the act their prog

4. INDIC


nization of chickens to provide passive immunisation against necrotic enteritis to ing the laying period.



To reduce mortality and the incidence and severity of lesions caused by Clostridium perfringens Type A induced necrotic enteritis. Efficacy was demonstrated by challenge of chicks approximately three er hatching.


The onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedu


The duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure


5. CONTRAINDI­CATIONS


None


6. ADVERSE REACTIONS




No systemic reactions to vaccination were seen following intramuscular vaccination. Vaccination may result in moderate swelling of the breast tissue which will resolve within 30 days. Following the second vaccination swelling may persist for at least 35 days. Swellingry common. After administration of a double dose, local reactions may increase sli



If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.


7. TARGET SPECIES


Chickens



8. DOSAGE FOR EACH SPECIES,


Vaccinate chickens by the intramuscular route in

One dose of 0.5 ml should be


D METHOD OF ADMINISTRATION


e breast.

given at 10 to 14 weeks of age.


A second dose of 0.5 ml should be administered 4 to 10 weeks after the first vaccination. The second dose should be administered no later than 6 weeks before the onset of lay.


9. ADVICE ON CORREC


ISTRATION


Shake well before use.

Syringes and needles must


e before use. Follow usual aseptic procedures.

10. WITHDRAWAL PERIOD

Zero days



11. SPE

ORAGE PRECAUTIONS


Keep oureach and sight of children.

Store ansport refrigerated (2°C- 8°C). Do not freeze.

Protect from light.

Do not use after the expiry date stated on the carton.

Shelf-life after first opening the immediate packaging: 8 hours


  • 12. SPECIAL WARNING(S)

Special precautions to be taken by the person administering the veterinary medicinal prod animals


To the user:

This product contains mineral oil. Accidental injection/self injection may result in se swelling, particularly if injected into a joint or finger, and in rare cases could result affected finger if prompt medical attention is not given.

If you are accidentally injected with this product, seek prompt medical advice ev small amount is injected and take the package leaflet with you.

in and of the


nly a very


If pain persists for more than 12 hours after medical examination, seek medical

gain.


To the physician:

This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

  • 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE

    MATERIALS, IF ANY


    14. DATE ON WHICH THE PAC

    15. OTHER INFORMATI

    AFLET WAS LAST APPROVED


    Any unused veterinary medicinal product or wa products should be disposed of in accordance


    als derived from such veterinary medicinal ional requirements.